As team lead for technology investments at M Ventures, Franke’s areas of investment focus included semiconductors, photonics, optics and compute.
Daniel Franke has left his role as executive investment director and team lead for technology investments at M Ventures, the corporate VC arm of German science and biotechnology company Merck KGaA.
A former GCV Rising Star, Franke joined M Ventures as an associate in 2019 after supporting the team as an analyst as part of the M Ventures fellowship. His areas of investment focus included semiconductors, photonics, optics and computer processors.
He did not disclose his next move.
M Ventures was founded in 2009 to invest in the biotechnology and technology sectors. The unit backs startups working on drug development, life science tools, electronics, frontier technology and sustainability.
See all the recent deals by M Ventures in the CVC Funding Round Database
Oishani Mitra is the content manager for Global Corporate Venturing.